Rajesh Shah

Rajesh Shah

Auto-generated profile, based on publicly available information

Rajesh Shah

Liggins Institute University of Auckland Auckland New Zealand

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2018 in Neonatology
Verified
Journal Article
Open access
PDF file
RSRajesh Shah
Rajesh Shah
JHJane Elizabeth Harding
Jane Elizabeth Harding
JBJulie Brown
Julie Brown
CMChristopher McKinlay
Christopher McKinlay
Background: Hypoglycaemia is the most common metabolic problem in neonates but there is no universally accepted threshold for safe blood glucose concentrations due to uncertainty regarding effects on neurodevelopment. Objective: To systematically assess the association between neonatal hypoglycaemia on neurodevelopment outcomes in childhood and adolescence. Methods: We searched MEDLINE, EMBASE, CINAHL, and PsycINFO from inception until February 2018. We included studies that reported one or more prespecified outcomes and compared children exposed to neonatal hypoglycaemia with children not exposed. Studies of neonates with congenital malformations, inherited metabolic disorders and congenital hyperinsulinism were excluded. Two authors independently extracted data using a customized form. We used ROBINS-I to assess risk of bias, GRADE for quality of evidence, and REVMAN for meta-analysis (inverse variance, fixed effects). Results: 1,665 studies were screened, 61 reviewed in full, and 11 included (12 publications). In early childhood, exposure to neonatal hypoglycaemia was not associated with neurodevelopmental impairment (n = 1,657 infants; OR = 1.16, 95% CI = 0.86–1.57) but was associated with visual-motor impairment (n = 508; OR = 3.46, 95% CI = 1.13–10.57) and executive dysfunction (n = 463; OR = 2.50, 95% CI = 1.20–5.22). In mid-childhood, neonatal hypoglycaemia was associated with neurodevelopmental impairment (n = 54; OR = 3.62, 95% CI = 1.05–12.42) and low literacy (n = 1,395; OR = 2.04, 95% CI = 1.20–3.47) and numeracy (n = 1,395; OR = 2.04, 95% CI = 1.21–3.44). No data were available for adolescents. Conclusions: Neonatal hypoglycaemia may have important long-lasting adverse effects on neurodevelopment that may become apparent at later ages. Carefully designed randomized trials are required to determine the optimal management of neonates at risk of hypoglycaemia with long-term follow-up at least to school age.

1 April 2018 in Current Opinion in Pediatrics
Verified
Journal Article
Closed access
RSRajesh Shah
Rajesh Shah
CMChristopher McKinlay
Christopher McKinlay
JHJane E. Harding
Jane E. Harding
Purpose of review: Continuous glucose monitoring (CGM) is increasingly used in the management of diabetes in children and adults, but there are few data regarding its use in neonates. The purpose of this article is to discuss the potential benefits and limitations of CGM in neonates. Recent findings: Smaller electrodes in new sensors and real-time monitoring have made CGM devices more approachable for neonatal care. CGM is well tolerated in infants including very low birth weight babies, and few if any local complications have been reported. Use of CGM in newborns may reduce the frequency of blood sampling and improve glycemic stability, with more time spent in the euglycemic range. However, CGM may also lead to more intervention, with potential adverse effects on outcomes. More information is also needed about reliability, calibration and interpretation of CGM in the neonate. Summary: Although the use of CGM in neonates appears to be well tolerated, feasible and has been associated with better glycemic status, there is not yet any evidence of improved clinical outcomes. Clinical utility of CGM should be demonstrated in randomized trials prior to its introduction into regular neonatal care.

17 June 2021 in Journal of Paediatrics and Child Health
Verified
Journal Article
Closed access
PDF file
RSRajesh Shah
Rajesh Shah
Gavin Thomas Lumsden BrownGavin Thomas Lumsden Brown
Gavin Thomas Lumsden Brown
PKPeter Keegan
Peter Keegan
JHJane Elizabeth Harding
Jane Elizabeth Harding
CMChristopher McKinlay
Christopher McKinlay
CGCHYLD Study Group
CHYLD Study Group

28 February 2020 in Journal of Paediatrics and Child Health
Verified
Journal Article
Closed access
PDF file
RSRajesh Shah
Rajesh Shah
Gavin Thomas Lumsden BrownGavin Thomas Lumsden Brown
Gavin Thomas Lumsden Brown
PKPeter Keegan
Peter Keegan
NBNataliia Burakevych
Nataliia Burakevych
JHJane Elizabeth Harding
Jane Elizabeth Harding
FGfor the CHYLD Study Group
for the CHYLD Study Group

31 January 2023 in Developmental Medicine & Child Neurology
Verified
Journal Article
Open access
DDDarren W. T. Dai
Darren W. T. Dai
NFNike Franke
Nike Franke
CMChristopher J. D. McKinlay
Christopher J. D. McKinlay
TWTrecia A. Wouldes
Trecia A. Wouldes
Gavin Thomas Lumsden BrownGavin Thomas Lumsden Brown
Gavin Thomas Lumsden Brown
FGfor the Children With Hypoglycaemia and Their Later Development (CHYLD) Study Group
for the Children With Hypoglycaemia and Their Later Development (CHYLD) Study Group
Aim: To examine the relationship between neonatal hypoglycaemia and specific areas of executive function and behaviour in mid‐childhood.Method: Participants in a prospective cohort study of infants born late preterm or at term at risk of neonatal hypoglycaemia were assessed at 9 to 10 years. We assessed executive function using performance‐based (Cambridge Neuropsychological Tests Automated Battery) and questionnaire‐based (Behavior Rating Inventory of Executive Function) measures and behaviour problems with the Strengths and Difficulties Questionnaire. Data are reported as adjusted odds ratio (aOR) with 95% confidence intervals, and standardized regression coefficients.Results: We assessed 480 (230 females, 250 males; mean age 9 years 5 months [SD 4 months, range 8 years 8 months–11 years 0 months]) of 587 eligible children (82%). There were no differences in performance‐based executive function between children who did and did not experience neonatal hypoglycaemia (blood glucose <2.6 mmoL/L). However, children who experienced hypoglycaemia, especially if severe or recurrent, were at greater risk of parent‐reported metacognition difficulties (aOR 2.37–3.71), parent‐reported peer (aOR 1.62–1.89) and teacher‐reported conduct (aOR 2.14 for severe hypoglycaemia) problems. Both performance‐ and questionnaire‐based executive functions were associated with behaviour problems.Interpretation: Neonatal hypoglycaemia may be associated with difficulties in specific aspects of parent‐reported executive functions and behaviour problems in mid‐childhood.